PALIPERIDONE

PALIPERIDONE was reported 32681 times

PALIPERIDONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CLANG ASSOCIATIONS 8 0.7273
1 ANOSOGNOSIA 390 0.5078
2 BLOOD PROLACTIN ABNORMAL 414 0.4797
3 HYPERPROLACTINAEMIA 1272 0.1960
4 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 24 0.1920
5 DISTURBANCE IN SOCIAL BEHAVIOUR 391 0.1658
6 GALACTORRHOEA 1060 0.1649
7 METAMYELOCYTE COUNT INCREASED 21 0.1409
8 ABNORMAL WEIGHT GAIN 1662 0.1344
9 GYNAECOMASTIA 3666 0.1184
10 MYELOCYTE COUNT INCREASED 22 0.1170
11 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 21 0.0913
12 BLOOD PROLACTIN INCREASED 403 0.0854
13 GENDER DYSPHORIA 7 0.0795
14 JAW CLICKING 15 0.0704
15 METABOLIC DISORDER 395 0.0680
16 POSTOPERATIVE RESPIRATORY FAILURE 7 0.0673
17 ILLITERACY 11 0.0659
18 INJURY 4328 0.0615
19 GENITAL NEOPLASM MALIGNANT FEMALE 7 0.0565
20 SCHIZOPHRENIA 670 0.0551
21 SCHIZOAFFECTIVE DISORDER 93 0.0521
22 HYPOMETABOLISM 18 0.0471
23 SCHIZOPHRENIFORM DISORDER 11 0.0453
24 BREAST DISCHARGE 79 0.0450
25 SEXUAL DYSFUNCTION 486 0.0414
26 SELF INJURIOUS BEHAVIOUR 126 0.0413
27 DYSDIADOCHOKINESIS 7 0.0409
28 PERSONALITY CHANGE 352 0.0379
29 REBOUND PSYCHOSIS 8 0.0376
30 SEDATION COMPLICATION 95 0.0372
31 DYSTONIA 715 0.0368
32 PSYCHOTIC SYMPTOM 75 0.0363
33 WATER INTOXICATION 17 0.0336
34 SCHIZOPHRENIA, PARANOID TYPE 12 0.0333
35 OBESITY 514 0.0322
36 HYPOAESTHESIA EYE 19 0.0322
37 EPILEPTIC ENCEPHALOPATHY 7 0.0314
38 HOUSEBOUND 12 0.0302
39 AKATHISIA 404 0.0296
40 SEDATION 762 0.0291
41 CARDIAC SEPTAL HYPERTROPHY 8 0.0289
42 ANTIPSYCHOTIC DRUG LEVEL DECREASED 15 0.0282
43 REGRESSIVE BEHAVIOUR 8 0.0275
44 BLUNTED AFFECT 20 0.0271
45 OCULOGYRIC CRISIS 56 0.0261
46 APRAXIA 38 0.0256
47 BLOOD OSMOLARITY DECREASED 16 0.0256
48 NEUROLEPTIC MALIGNANT SYNDROME 292 0.0246
49 EXTRAPYRAMIDAL DISORDER 608 0.0245
50 PERSECUTORY DELUSION 61 0.0244
51 PLEUROTHOTONUS 22 0.0243
52 METABOLIC SYNDROME 40 0.0243
53 CATATONIA 125 0.0238
54 HALLUCINATION, AUDITORY 363 0.0228
55 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 20 0.0225
56 SOLILOQUY 19 0.0220
57 TRICHOGLOSSIA 9 0.0220
58 HEAD TITUBATION 30 0.0218
59 PAINFUL ERECTION 15 0.0218
60 PARKINSONISM 210 0.0215
61 BLOOD OSMOLARITY INCREASED 7 0.0213
62 BREAST ENLARGEMENT 69 0.0210
63 BLOOD LACTATE DEHYDROGENASE DECREASED 7 0.0210
64 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 14 0.0203
65 PERSISTENT DEPRESSIVE DISORDER 8 0.0198
66 INSULIN AUTOIMMUNE SYNDROME 7 0.0196
67 DELUSIONAL PERCEPTION 8 0.0193
68 DROOLING 133 0.0192
69 DELUSION 299 0.0192
70 EMOTIONAL DISORDER 591 0.0191
71 LACTATION DISORDER 9 0.0185
72 MYOCARDITIS 209 0.0182
73 NEPHROGENIC DIABETES INSIPIDUS 21 0.0182
74 MONOCYTE COUNT DECREASED 22 0.0180
75 DYSKINESIA 717 0.0176
76 ANION GAP INCREASED 23 0.0172
77 OVERWEIGHT 92 0.0171
78 PSYCHOTIC DISORDER 494 0.0167
79 POLYDIPSIA 66 0.0167
80 COGWHEEL RIGIDITY 17 0.0162
81 BLOOD UREA DECREASED 20 0.0161
82 INDIFFERENCE 12 0.0160
83 SALIVARY HYPERSECRETION 158 0.0158
84 SUSPICIOUSNESS 11 0.0156
85 PSYCHIATRIC DECOMPENSATION 30 0.0153
86 PERSONALITY DISORDER 39 0.0149
87 BLOOD BICARBONATE INCREASED 7 0.0146
88 TONGUE MOVEMENT DISTURBANCE 12 0.0140
89 C-REACTIVE PROTEIN DECREASED 9 0.0138
90 ORTHOSTATIC HYPERTENSION 8 0.0137
91 PROTRUSION TONGUE 8 0.0137
92 TROPONIN I INCREASED 22 0.0132
93 ANTIPSYCHOTIC DRUG LEVEL INCREASED 36 0.0128
94 INAPPROPRIATE AFFECT 20 0.0126
95 TREATMENT NONCOMPLIANCE 684 0.0125
96 PRIAPISM 43 0.0125
97 DRUG-DISEASE INTERACTION 9 0.0123
98 SOCIAL ANXIETY DISORDER 8 0.0122
99 FLASHBACK 7 0.0121
100 TARDIVE DYSKINESIA 340 0.0120
101 DELUSIONAL DISORDER, UNSPECIFIED TYPE 9 0.0120
102 SOMATIC SYMPTOM DISORDER 13 0.0120
103 MULTIPLE DRUG THERAPY 9 0.0119
104 THOUGHT BLOCKING 7 0.0119
105 HEAT ILLNESS 8 0.0119
106 PSYCHOTIC BEHAVIOUR 12 0.0118
107 ACIDOSIS HYPERCHLORAEMIC 7 0.0118
108 INTENTIONAL SELF-INJURY 237 0.0117
109 QRS AXIS ABNORMAL 9 0.0117
110 DYSMETRIA 7 0.0116
111 MEAN CELL HAEMOGLOBIN DECREASED 21 0.0115
112 STARING 27 0.0112
113 AMENORRHOEA 195 0.0111
114 SUICIDE ATTEMPT 672 0.0111
115 ANTISOCIAL BEHAVIOUR 11 0.0110
116 BEZOAR 15 0.0109
117 TORTICOLLIS 23 0.0108
118 CONVERSION DISORDER 21 0.0108
119 MANIA 176 0.0107
120 THERAPEUTIC RESPONSE INCREASED 10 0.0106
121 ELECTROCARDIOGRAM CHANGE 10 0.0105
122 ACUTE PSYCHOSIS 26 0.0105
123 BLAST CELL COUNT INCREASED 11 0.0105
124 POST-INJECTION DELIRIUM SEDATION SYNDROME 9 0.0104
125 PSYCHIATRIC SYMPTOM 77 0.0104
126 ILLUSION 17 0.0103
127 RETROGRADE EJACULATION 8 0.0101
128 EJACULATION FAILURE 20 0.0100
129 PARANOIA 166 0.0096
130 SYMPTOM MASKED 7 0.0096
131 SYSTOLIC DYSFUNCTION 10 0.0095
132 TROPONIN T INCREASED 12 0.0095
133 PITUITARY TUMOUR 14 0.0094
134 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 21 0.0094
135 DEPRESSIVE SYMPTOM 33 0.0094
136 SOCIAL AVOIDANT BEHAVIOUR 54 0.0093
137 BASOPHIL COUNT INCREASED 7 0.0092
138 HYPERAMMONAEMIC ENCEPHALOPATHY 16 0.0092
139 PITUITARY TUMOUR BENIGN 15 0.0092
140 ELECTROCARDIOGRAM PR PROLONGATION 7 0.0092
141 DIABETES INSIPIDUS 22 0.0091
142 CREATINE KINASE INCREASED 7 0.0091
143 ABDOMINAL SEPSIS 8 0.0091
144 MEAN CELL VOLUME DECREASED 14 0.0091
145 BLOOD BICARBONATE DECREASED 17 0.0090
146 HYPERPHAGIA 35 0.0088
147 APATHY 128 0.0088
148 AKINESIA 18 0.0087
149 MUSCLE RIGIDITY 103 0.0086
150 EMOTIONAL POVERTY 15 0.0086
151 BLOOD SODIUM INCREASED 23 0.0085
152 TRISMUS 44 0.0085
153 IMPRISONMENT 15 0.0085
154 MULTIPLE DRUG OVERDOSE INTENTIONAL 27 0.0084
155 PULMONARY VALVE INCOMPETENCE 12 0.0082
156 ANTICHOLINERGIC SYNDROME 13 0.0082
157 TROPONIN INCREASED 61 0.0080
158 CEREBELLAR ATROPHY 7 0.0079
159 PHOBIA 9 0.0079
160 LANGUAGE DISORDER 17 0.0079
161 BREAST SWELLING 21 0.0078
162 SINUS TACHYCARDIA 110 0.0077
163 DISORGANISED SPEECH 14 0.0076
164 BRUXISM 40 0.0074
165 DELAYED RECOVERY FROM ANAESTHESIA 7 0.0074
166 HALLUCINATIONS, MIXED 31 0.0074
167 PARADOXICAL DRUG REACTION 27 0.0073
168 INFERTILITY 11 0.0073
169 LOSS OF LIBIDO 65 0.0072
170 REFUSAL OF TREATMENT BY PATIENT 47 0.0072
171 SLUGGISHNESS 73 0.0071
172 MENTAL IMPAIRMENT 173 0.0071
173 HOSTILITY 18 0.0071
174 SLOW SPEECH 17 0.0070
175 BLOOD CHLORIDE DECREASED 18 0.0070
176 FALSE POSITIVE INVESTIGATION RESULT 7 0.0069
177 MUTISM 10 0.0069
178 BREAST DISORDER 14 0.0069
179 INCREASED APPETITE 129 0.0067
180 AGGRESSION 327 0.0065
181 ENURESIS 26 0.0064
182 PROTEIN TOTAL INCREASED 17 0.0064
183 BIPOLAR I DISORDER 14 0.0064
184 YAWNING 17 0.0064
185 SOPOR 84 0.0063
186 LOGORRHOEA 22 0.0062
187 TIC 34 0.0062
188 RESTLESSNESS 228 0.0062
189 WEIGHT INCREASED 1391 0.0062
190 SLOW RESPONSE TO STIMULI 8 0.0062
191 PARAPARESIS 11 0.0062
192 EYE MOVEMENT DISORDER 42 0.0061
193 THINKING ABNORMAL 114 0.0061
194 PSYCHOMOTOR RETARDATION 17 0.0060
195 FLAT AFFECT 14 0.0060
196 HIRSUTISM 8 0.0060
197 COMMUNICATION DISORDER 23 0.0060
198 HIGH DENSITY LIPOPROTEIN DECREASED 20 0.0060
199 BIPOLAR DISORDER 65 0.0060
200 GAMBLING DISORDER 16 0.0059
201 HYPERTONIC BLADDER 17 0.0059
202 EOSINOPHIL COUNT DECREASED 14 0.0059
203 GAZE PALSY 10 0.0059
204 ELECTROCARDIOGRAM T WAVE ABNORMAL 9 0.0058
205 HOMICIDAL IDEATION 23 0.0057
206 ANORGASMIA 15 0.0055
207 ABNORMAL BEHAVIOUR 218 0.0055
208 HYPOTHALAMO-PITUITARY DISORDER 8 0.0055
209 OBSESSIVE-COMPULSIVE DISORDER 44 0.0055
210 MYOCLONUS 65 0.0054
211 INSURANCE ISSUE 83 0.0054
212 LIBIDO DISORDER 7 0.0054
213 IMPULSIVE BEHAVIOUR 20 0.0053
214 INTENTIONAL OVERDOSE 338 0.0053
215 MONOCYTE COUNT INCREASED 19 0.0052
216 BEHAVIOUR DISORDER 28 0.0052
217 AUTONOMIC NERVOUS SYSTEM IMBALANCE 15 0.0051
218 SUBSTANCE USE 8 0.0051
219 VENTRICULAR HYPOKINESIA 16 0.0050
220 BLEPHAROSPASM 31 0.0049
221 HYPOMANIA 18 0.0049
222 DRUG LEVEL BELOW THERAPEUTIC 27 0.0049
223 COMPULSIVE SHOPPING 10 0.0049
224 HAEMATOCRIT INCREASED 11 0.0048
225 BODY TEMPERATURE FLUCTUATION 10 0.0048
226 INVESTIGATION 15 0.0048
227 LEFT VENTRICULAR DYSFUNCTION 32 0.0048
228 EXCESSIVE EYE BLINKING 7 0.0047
229 TOBACCO USER 7 0.0047
230 SKIN STRIAE 7 0.0047
231 STUPOR 15 0.0047
232 BLOOD CREATINE PHOSPHOKINASE INCREASED 134 0.0047
233 ERECTILE DYSFUNCTION 119 0.0046
234 TACHYPHRENIA 16 0.0046
235 BRADYPHRENIA 30 0.0046
236 EJACULATION DISORDER 13 0.0046
237 ACCIDENTAL DRUG INTAKE BY CHILD 7 0.0046
238 HYPERTONIA 26 0.0045
239 FOOD INTERACTION 8 0.0045
240 LIPIDS INCREASED 9 0.0045
241 ORTHOSTATIC HYPOTENSION 77 0.0044
242 SUDDEN CARDIAC DEATH 15 0.0044
243 AGITATION 322 0.0044
244 HYPERSEXUALITY 8 0.0044
245 CONDUCTION DISORDER 8 0.0044
246 RED BLOOD CELL COUNT INCREASED 12 0.0043
247 HYPOTHERMIA 44 0.0043
248 IMPAIRED SELF-CARE 9 0.0043
249 MUSCLE TWITCHING 100 0.0043
250 CONGESTIVE CARDIOMYOPATHY 18 0.0043
251 LOSS OF EMPLOYMENT 13 0.0043
252 CARDIOVASCULAR INSUFFICIENCY 7 0.0043
253 RHABDOMYOLYSIS 179 0.0043
254 SELF-INJURIOUS IDEATION 18 0.0043
255 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 44 0.0043
256 HYPERSOMNIA 121 0.0042
257 GRANULOCYTOPENIA 24 0.0042
258 TACHYCARDIA 374 0.0042
259 PSYCHOMOTOR SKILLS IMPAIRED 11 0.0042
260 ATRIOVENTRICULAR BLOCK FIRST DEGREE 18 0.0041
261 HALLUCINATION, VISUAL 87 0.0041
262 SOCIAL PROBLEM 17 0.0041
263 HYPERTRIGLYCERIDAEMIA 24 0.0041
264 GLUCOSE TOLERANCE IMPAIRED 24 0.0041
265 GASTROINTESTINAL HYPOMOTILITY 9 0.0040
266 HALLUCINATION 298 0.0040
267 DYSLIPIDAEMIA 20 0.0039
268 DRUG TOLERANCE DECREASED 11 0.0039
269 DRUG MONITORING PROCEDURE NOT PERFORMED 7 0.0039
270 HYPERGLYCAEMIA 142 0.0039
271 DIASTOLIC DYSFUNCTION 12 0.0039
272 MEDICATION RESIDUE 10 0.0039
273 ELECTROCARDIOGRAM QT PROLONGED 139 0.0039
274 ALTERED STATE OF CONSCIOUSNESS 83 0.0038
275 PHYSICAL ASSAULT 8 0.0038
276 DRUG USE DISORDER 32 0.0038
277 HOMICIDE 7 0.0038
278 SUICIDAL IDEATION 346 0.0038
279 BUNDLE BRANCH BLOCK LEFT 16 0.0038
280 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10 0.0038
281 AFFECT LABILITY 36 0.0037
282 MUSCLE TIGHTNESS 60 0.0037
283 LYMPHOCYTE COUNT INCREASED 12 0.0037
284 PSYCHOMOTOR HYPERACTIVITY 61 0.0037
285 IMMOBILE 16 0.0037
286 DYSPHEMIA 16 0.0036
287 NEAR DEATH EXPERIENCE 12 0.0036
288 ELECTROCARDIOGRAM T WAVE INVERSION 8 0.0036
289 SUICIDAL BEHAVIOUR 15 0.0036
290 ADVERSE DRUG REACTION 322 0.0036
291 LARGE INTESTINAL OBSTRUCTION 8 0.0036
292 AFFECTIVE DISORDER 28 0.0036
293 BLOOD CREATININE DECREASED 11 0.0035
294 ADVERSE EVENT 322 0.0035
295 TYPE 1 DIABETES MELLITUS 21 0.0035
296 LIBIDO INCREASED 7 0.0034
297 MUSCLE CONTRACTURE 7 0.0034
298 SNORING 13 0.0034
299 BLOOD TRIGLYCERIDES INCREASED 60 0.0034
300 POSTURE ABNORMAL 11 0.0034
301 HOSPITALISATION 517 0.0034
302 THERAPEUTIC PRODUCT INEFFECTIVE 13 0.0034
303 MEDICATION RESIDUE PRESENT 16 0.0033
304 TREMOR 553 0.0033
305 DELIRIUM 114 0.0033
306 VENTRICULAR ARRHYTHMIA 12 0.0033
307 MASTICATION DISORDER 10 0.0033
308 SUPRAVENTRICULAR EXTRASYSTOLES 11 0.0033
309 DRUG SCREEN FALSE POSITIVE 9 0.0032
310 INFECTION SUSCEPTIBILITY INCREASED 7 0.0032
311 PROTEIN TOTAL DECREASED 12 0.0032
312 BLOOD ALBUMIN DECREASED 25 0.0031
313 TEMPERATURE REGULATION DISORDER 7 0.0031
314 EXERCISE TOLERANCE DECREASED 18 0.0031
315 NEUTROPHIL COUNT INCREASED 32 0.0031
316 PHYSICAL DECONDITIONING 8 0.0031
317 MENTAL DISORDER 135 0.0031
318 DYSARTHRIA 116 0.0031
319 NEGATIVE THOUGHTS 9 0.0031
320 SUBSTANCE ABUSE 25 0.0031
321 URINE OUTPUT INCREASED 8 0.0031
322 BREAST TENDERNESS 23 0.0031
323 PEMPHIGOID 23 0.0030
324 DRUG LEVEL DECREASED 31 0.0030
325 ANGER 103 0.0030
326 MOVEMENT DISORDER 97 0.0030
327 EMOTIONAL DISTRESS 365 0.0030
328 MAJOR DEPRESSION 22 0.0030
329 ALCOHOL ABUSE 8 0.0030
330 ALCOHOL USE 11 0.0030
331 SOMNOLENCE 597 0.0030
332 VOLVULUS 7 0.0030
333 MULTIPLE-DRUG RESISTANCE 9 0.0029
334 TRICUSPID VALVE INCOMPETENCE 23 0.0029
335 HYPERREFLEXIA 10 0.0029
336 COMPLETED SUICIDE 235 0.0028
337 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
338 DRUG SCREEN POSITIVE 22 0.0028
339 DRUG INTERACTION 441 0.0028
340 ASPIRATION 30 0.0027
341 URINARY INCONTINENCE 81 0.0027
342 RESTLESS LEGS SYNDROME 49 0.0027
343 POTENTIATING DRUG INTERACTION 9 0.0027
344 DIZZINESS POSTURAL 26 0.0027
345 DRUG LEVEL INCREASED 44 0.0027
346 ABNORMAL LOSS OF WEIGHT 18 0.0026
347 INCOHERENT 17 0.0026
348 TONGUE DISORDER 19 0.0026
349 BLOOD GLUCOSE INCREASED 493 0.0026
350 SEROTONIN SYNDROME 50 0.0026
351 HYPONATRAEMIA 145 0.0026
352 DRUG RESISTANCE 66 0.0026
353 DYSPHORIA 13 0.0026
354 CEREBRAL DISORDER 19 0.0026
355 BLOOD PHOSPHORUS INCREASED 7 0.0026
356 FAECALOMA 14 0.0026
357 NONSPECIFIC REACTION 14 0.0025
358 PRODUCT USE IN UNAPPROVED INDICATION 632 0.0025
359 ELECTROCARDIOGRAM ABNORMAL 20 0.0025
360 BRADYKINESIA 15 0.0025
361 BRAIN INJURY 25 0.0025
362 TENDON DISORDER 16 0.0025
363 HUNGER 34 0.0024
364 AGRANULOCYTOSIS 45 0.0024
365 COMA SCALE ABNORMAL 7 0.0024
366 HYPERAMMONAEMIA 12 0.0024
367 BUNDLE BRANCH BLOCK RIGHT 11 0.0024
368 MITRAL VALVE INCOMPETENCE 27 0.0024
369 STRABISMUS 7 0.0024
370 COLITIS ISCHAEMIC 16 0.0024
371 RESPIRATORY DEPRESSION 29 0.0024
372 THORACIC VERTEBRAL FRACTURE 7 0.0024
373 AUTISM SPECTRUM DISORDER 13 0.0024
374 ANHEDONIA 62 0.0024
375 SCREAMING 15 0.0024
376 DRUG PRESCRIBING ERROR 45 0.0023
377 SWOLLEN TONGUE 73 0.0023
378 REBOUND ACID HYPERSECRETION 7 0.0023
379 TENSION 14 0.0023
380 ISCHAEMIC CARDIOMYOPATHY 7 0.0023
381 DISTURBANCE IN ATTENTION 123 0.0023
382 INCONTINENCE 24 0.0023
383 LYMPHOCYTE COUNT DECREASED 40 0.0023
384 CEREBRAL ATROPHY 9 0.0023
385 FRUSTRATION TOLERANCE DECREASED 18 0.0022
386 HYPERTHERMIA 17 0.0022
387 SPEECH DISORDER 116 0.0022
388 TESTICULAR PAIN 7 0.0022
389 DRUG ABUSE 183 0.0022
390 IRRITABILITY 132 0.0022
391 SELF-MEDICATION 9 0.0022
392 MENSTRUAL DISORDER 18 0.0022
393 TYPE 2 DIABETES MELLITUS 73 0.0022
394 MOTOR DYSFUNCTION 22 0.0022
395 HYPERPYREXIA 9 0.0021
396 THERAPY CESSATION 108 0.0021
397 OROPHARYNGEAL DISCOMFORT 19 0.0021
398 ASPHYXIA 17 0.0021
399 SUDDEN DEATH 22 0.0021
400 MUSCULOSKELETAL STIFFNESS 182 0.0021
401 POLYURIA 17 0.0021
402 THIRST 37 0.0021
403 POISONING 26 0.0021
404 PANIC DISORDER 8 0.0021
405 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 14 0.0021
406 HORMONE LEVEL ABNORMAL 10 0.0020
407 BLOOD TESTOSTERONE DECREASED 14 0.0020
408 INITIAL INSOMNIA 21 0.0020
409 PNEUMONIA ASPIRATION 51 0.0020
410 ARRHYTHMIA 96 0.0020
411 ILEUS 25 0.0020
412 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 142 0.0020
413 MUSCLE CONTRACTIONS INVOLUNTARY 7 0.0020
414 SINUS BRADYCARDIA 19 0.0020
415 LETHARGY 113 0.0020
416 AMMONIA INCREASED 10 0.0020
417 PETIT MAL EPILEPSY 10 0.0020
418 POST-TRAUMATIC STRESS DISORDER 13 0.0019
419 CONFUSIONAL STATE 313 0.0019
420 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
421 BLOOD SODIUM DECREASED 36 0.0019
422 MENTAL STATUS CHANGES 53 0.0019
423 BLOOD URIC ACID INCREASED 11 0.0019
424 GAMMA-GLUTAMYLTRANSFERASE INCREASED 42 0.0019
425 CARDIOMYOPATHY 28 0.0019
426 WITHDRAWAL SYNDROME 79 0.0019
427 HYPERACUSIS 7 0.0019
428 THERAPEUTIC RESPONSE DECREASED 114 0.0019
429 HEPATIC STEATOSIS 35 0.0019
430 MIOSIS 15 0.0019
431 C-REACTIVE PROTEIN INCREASED 68 0.0019
432 ALCOHOLISM 8 0.0019
433 HYPOKINESIA 27 0.0019
434 URINARY RETENTION 62 0.0019
435 EUPHORIC MOOD 19 0.0019
436 COMA 88 0.0018
437 HYPERLIPIDAEMIA 22 0.0018
438 ASTHENOPIA 10 0.0018
439 EXPIRED DRUG ADMINISTERED 9 0.0018
440 MULTIPLE DRUG OVERDOSE 9 0.0018
441 DEPRESSION 411 0.0018
442 DIABETES MELLITUS 137 0.0018
443 OFF LABEL USE 1565 0.0018
444 DEPRESSED MOOD 94 0.0018
445 HYPERCHOLESTEROLAEMIA 17 0.0018
446 NEUTROPHILIA 10 0.0018
447 INSOMNIA 468 0.0018
448 LIVER FUNCTION TEST ABNORMAL 51 0.0018
449 SLEEP APNOEA SYNDROME 33 0.0017
450 PERICARDITIS 29 0.0017
451 BRAIN FOG 27 0.0017
452 DEPRESSED LEVEL OF CONSCIOUSNESS 68 0.0017
453 CONDITION AGGRAVATED 522 0.0017
454 DECREASED INTEREST 10 0.0017
455 DRUG ADMINISTRATION ERROR 52 0.0017
456 TACHYPNOEA 23 0.0017
457 BREAST PAIN 18 0.0017
458 EOSINOPHIL COUNT INCREASED 14 0.0017
459 WRONG TECHNIQUE IN DRUG USAGE PROCESS 61 0.0017
460 BLOOD CHOLESTEROL INCREASED 78 0.0017
461 SYMPTOM RECURRENCE 10 0.0017
462 THERAPY PARTIAL RESPONDER 26 0.0017
463 LEUKOPENIA 83 0.0017
464 LEUKOCYTOSIS 30 0.0017
465 INTENTIONAL PRODUCT MISUSE 145 0.0017
466 NIGHTMARE 57 0.0016
467 AORTIC VALVE INCOMPETENCE 7 0.0016
468 TOXICITY TO VARIOUS AGENTS 277 0.0016
469 BREAST MASS 11 0.0016
470 DRUG DISPENSING ERROR 25 0.0016
471 ANXIETY 464 0.0016
472 ABNORMAL SENSATION IN EYE 7 0.0016
473 MOOD ALTERED 44 0.0016
474 HYPERNATRAEMIA 8 0.0016
475 MUSCLE DISORDER 13 0.0016
476 PRE-EXISTING CONDITION IMPROVED 10 0.0016
477 PANIC ATTACK 58 0.0016
478 COGNITIVE DISORDER 74 0.0016
479 PRODUCT ADMINISTRATION ERROR 32 0.0016
480 DRUG DOSE OMISSION 261 0.0016
481 DRY THROAT 16 0.0016
482 DISSOCIATION 12 0.0016
483 PRODUCT USE ISSUE 294 0.0016
484 FEAR 42 0.0016
485 DISORIENTATION 61 0.0015
486 HYPOTHYROIDISM 49 0.0015
487 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
488 LUMBAR VERTEBRAL FRACTURE 7 0.0015
489 FOOD CRAVING 8 0.0015
490 GENERALISED TONIC-CLONIC SEIZURE 25 0.0015
491 EPILEPSY 46 0.0015
492 EATING DISORDER 32 0.0015
493 HYPOTONIA 15 0.0015
494 FEELING OF DESPAIR 7 0.0015
495 POOR QUALITY SLEEP 32 0.0015
496 PRODUCT RESIDUE PRESENT 8 0.0015
497 MYDRIASIS 19 0.0015
498 DYSPHAGIA 140 0.0015
499 IMPAIRED GASTRIC EMPTYING 20 0.0015
500 DYSURIA 54 0.0015
501 ENCEPHALOPATHY 36 0.0015
502 DIABETIC KETOACIDOSIS 35 0.0015
503 GENERALISED OEDEMA 18 0.0015
504 CONVULSION 83 0.0014
505 PRESCRIBED OVERDOSE 28 0.0014
506 ANAL INCONTINENCE 13 0.0014
507 HAEMATOCRIT DECREASED 28 0.0014
508 TORSADE DE POINTES 11 0.0014
509 NOCTURIA 17 0.0014
510 SEIZURE 160 0.0014
511 DRUG TOLERANCE 7 0.0014
512 HYPERHIDROSIS 178 0.0014
513 POLLAKIURIA 57 0.0014
514 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 7 0.0014
515 PRODUCT COLOUR ISSUE 7 0.0014
516 DRUG INEFFECTIVE 1796 0.0014
517 ENERGY INCREASED 8 0.0014
518 TREATMENT FAILURE 112 0.0014
519 EJECTION FRACTION DECREASED 21 0.0013
520 ATAXIA 16 0.0013
521 VISION BLURRED 185 0.0013
522 HEART RATE INCREASED 133 0.0013
523 PANCREATITIS ACUTE 30 0.0013
524 DRY MOUTH 108 0.0013
525 BLOOD LACTIC ACID INCREASED 7 0.0013
526 DRUG ADMINISTERED AT INAPPROPRIATE SITE 14 0.0013
527 SERUM FERRITIN INCREASED 7 0.0013
528 THERAPY CHANGE 13 0.0013
529 IMPAIRED QUALITY OF LIFE 19 0.0013
530 SLEEP DISORDER 93 0.0013
531 PULMONARY EMBOLISM 125 0.0013
532 EOSINOPHILIA 23 0.0013
533 HAEMODYNAMIC INSTABILITY 10 0.0013
534 WHITE BLOOD CELL COUNT INCREASED 50 0.0013
535 THROAT TIGHTNESS 35 0.0013
536 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 71 0.0013
537 ATRIOVENTRICULAR BLOCK 10 0.0013
538 OVERDOSE 279 0.0013
539 OLIGURIA 8 0.0013
540 NEUTROPENIA 175 0.0013
541 MOOD SWINGS 41 0.0013
542 HEPATIC FUNCTION ABNORMAL 48 0.0013
543 DRUG EFFECT DECREASED 69 0.0013
544 BODY TEMPERATURE INCREASED 26 0.0013
545 FRACTURE 24 0.0013
546 CRYING 46 0.0013
547 HYPOAESTHESIA ORAL 19 0.0013
548 GINGIVAL PAIN 10 0.0013
549 PALPITATIONS 147 0.0013
550 ECONOMIC PROBLEM 19 0.0013
551 VENTRICULAR EXTRASYSTOLES 13 0.0013
552 REBOUND EFFECT 14 0.0012
553 CONSTIPATION 269 0.0012
554 CARDIOTOXICITY 11 0.0012
555 HEPATITIS ACUTE 8 0.0012
556 MYOCARDIAL ISCHAEMIA 14 0.0012
557 COELIAC DISEASE 12 0.0012
558 INTESTINAL OBSTRUCTION 46 0.0012
559 SPINAL COMPRESSION FRACTURE 10 0.0012
560 FEELING ABNORMAL 288 0.0012
561 FEELING OF BODY TEMPERATURE CHANGE 7 0.0012
562 PRODUCT DISPENSING ERROR 26 0.0012
563 PARALYSIS 17 0.0012
564 BRAIN OEDEMA 15 0.0012
565 WRONG PRODUCT ADMINISTERED 8 0.0012
566 SENSORY DISTURBANCE 19 0.0012
567 AMNESIA 77 0.0012
568 INJECTION SITE NODULE 13 0.0012
569 ACIDOSIS 9 0.0012
570 THERAPEUTIC PRODUCT EFFECT DECREASED 52 0.0012
571 ALANINE AMINOTRANSFERASE INCREASED 71 0.0012
572 MULTIPLE ALLERGIES 9 0.0011
573 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
574 LYMPHOPENIA 16 0.0011
575 WRONG DRUG ADMINISTERED 10 0.0011
576 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8 0.0011
577 RHINITIS 9 0.0011
578 HYPOTENSION 223 0.0011
579 PHOTOPSIA 7 0.0011
580 HEART RATE IRREGULAR 25 0.0011
581 THERAPEUTIC RESPONSE CHANGED 7 0.0011
582 SKIN LACERATION 12 0.0011
583 HEPATIC CYTOLYSIS 14 0.0011
584 GRAND MAL CONVULSION 10 0.0011
585 FEELING DRUNK 8 0.0011
586 ADRENAL INSUFFICIENCY 13 0.0011
587 FACE OEDEMA 18 0.0011
588 SOMNAMBULISM 7 0.0011
589 DISABILITY 21 0.0011
590 ACTIVITIES OF DAILY LIVING IMPAIRED 21 0.0011
591 HYPOPHAGIA 27 0.0011
592 TOOTHACHE 19 0.0010
593 FEELING JITTERY 20 0.0010
594 UNRESPONSIVE TO STIMULI 27 0.0010
595 BRADYCARDIA 55 0.0010
596 CHOKING 20 0.0010
597 DECREASED ACTIVITY 11 0.0010
598 HEAD DISCOMFORT 18 0.0010
599 LOSS OF CONSCIOUSNESS 128 0.0010
600 PLATELET COUNT INCREASED 13 0.0010
601 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17 0.0010
602 TRANSAMINASES INCREASED 22 0.0010
603 TOXIC EPIDERMAL NECROLYSIS 15 0.0010
604 ACUTE RESPIRATORY FAILURE 19 0.0010
605 NEUTROPHIL COUNT DECREASED 40 0.0010
606 FEAR OF INJECTION 7 0.0010
607 ASPARTATE AMINOTRANSFERASE INCREASED 52 0.0010
608 STATUS EPILEPTICUS 11 0.0010
609 CHEST PAIN 180 0.0010
610 PANIC REACTION 7 0.0010
611 QUALITY OF LIFE DECREASED 13 0.0010
612 IMPAIRED DRIVING ABILITY 11 0.0010
613 EXPOSURE DURING PREGNANCY 60 0.0010
614 ERYTHEMA MULTIFORME 9 0.0010
615 PERICARDIAL EFFUSION 22 0.0010
616 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
617 OEDEMA PERIPHERAL 115 0.0009
618 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 67 0.0009
619 RENAL IMPAIRMENT 79 0.0009
620 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
621 SYNCOPE 94 0.0009
622 IMPAIRED WORK ABILITY 20 0.0009
623 CARDIO-RESPIRATORY ARREST 39 0.0009
624 DRUG INTOLERANCE 90 0.0009
625 APHONIA 13 0.0009
626 PAROSMIA 7 0.0009
627 MEMORY IMPAIRMENT 127 0.0009
628 BOWEL MOVEMENT IRREGULARITY 7 0.0009
629 BLOOD GLUCOSE FLUCTUATION 10 0.0009
630 INTENTIONAL DRUG MISUSE 19 0.0009
631 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
632 NERVOUSNESS 47 0.0009
633 MEDICATION ERROR 50 0.0009
634 MUSCULAR WEAKNESS 102 0.0009
635 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 43 0.0009
636 DEMENTIA 25 0.0009
637 THERAPY NON-RESPONDER 40 0.0009
638 PRODUCT PRESCRIBING ERROR 21 0.0009
639 BALANCE DISORDER 76 0.0009
640 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
641 GAIT INABILITY 29 0.0009
642 IRON DEFICIENCY ANAEMIA 8 0.0009
643 WEIGHT FLUCTUATION 9 0.0009
644 WHITE BLOOD CELL COUNT DECREASED 92 0.0008
645 BLOOD UREA INCREASED 14 0.0008
646 IMMUNE SYSTEM DISORDER 11 0.0008
647 RESPIRATORY DISTRESS 23 0.0008
648 ADVERSE REACTION 11 0.0008
649 ATELECTASIS 8 0.0008
650 MUSCLE SPASMS 151 0.0008
651 MENSTRUATION IRREGULAR 22 0.0008
652 VITAMIN D DEFICIENCY 8 0.0008
653 HEPATOMEGALY 8 0.0008
654 BLOOD GLUCOSE ABNORMAL 15 0.0008
655 PRODUCT DOSE OMISSION 53 0.0008
656 BLOOD MAGNESIUM DECREASED 7 0.0008
657 MALNUTRITION 9 0.0008
658 PHOTOPHOBIA 15 0.0008
659 ABNORMAL DREAMS 22 0.0008
660 DERMATITIS ALLERGIC 10 0.0008
661 MUSCLE ATROPHY 10 0.0008
662 COORDINATION ABNORMAL 11 0.0008
663 METABOLIC ACIDOSIS 25 0.0008
664 GAIT DISTURBANCE 149 0.0008
665 TEMPERATURE INTOLERANCE 8 0.0008
666 ELECTROLYTE IMBALANCE 9 0.0008
667 LIVER INJURY 19 0.0008
668 ABASIA 19 0.0008
669 ANGINA PECTORIS 22 0.0008
670 TENDERNESS 8 0.0008
671 END STAGE RENAL DISEASE 14 0.0008
672 HIDRADENITIS 7 0.0008
673 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 138 0.0008
674 PARAESTHESIA ORAL 11 0.0008
675 DIZZINESS 380 0.0008
676 APHASIA 23 0.0008
677 BEDRIDDEN 10 0.0008
678 MYALGIA 128 0.0008
679 MIDDLE INSOMNIA 14 0.0007
680 PRODUCT AVAILABILITY ISSUE 17 0.0007
681 MENSTRUATION DELAYED 8 0.0007
682 COLD SWEAT 13 0.0007
683 HEPATIC ENZYME INCREASED 50 0.0007
684 DRUG-INDUCED LIVER INJURY 23 0.0007
685 RESPIRATORY FAILURE 53 0.0007
686 CYST 9 0.0007
687 JOINT STIFFNESS 19 0.0007
688 DEEP VEIN THROMBOSIS 47 0.0007
689 CHEST DISCOMFORT 74 0.0007
690 STEVENS-JOHNSON SYNDROME 16 0.0007
691 FEELING COLD 20 0.0007
692 PHARYNGEAL OEDEMA 11 0.0007
693 THERAPEUTIC RESPONSE UNEXPECTED 32 0.0007
694 LACTIC ACIDOSIS 23 0.0007
695 VISUAL IMPAIRMENT 88 0.0007
696 HEPATOCELLULAR INJURY 10 0.0007
697 PRESYNCOPE 17 0.0007
698 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
699 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
700 OEDEMA 37 0.0007
701 ACUTE KIDNEY INJURY 103 0.0007
702 HYPOKALAEMIA 31 0.0007
703 INCORRECT DOSE ADMINISTERED 152 0.0007
704 HYPOGLYCAEMIA 32 0.0007
705 BLOOD CREATININE INCREASED 43 0.0007
706 RETCHING 14 0.0007
707 RASH GENERALISED 17 0.0007
708 DIPLOPIA 17 0.0007
709 IRRITABLE BOWEL SYNDROME 14 0.0007
710 DISEASE RECURRENCE 31 0.0007
711 CARDIOMEGALY 8 0.0006
712 DEAFNESS 17 0.0006
713 CONJUNCTIVITIS 12 0.0006
714 SKIN REACTION 9 0.0006
715 HYPERTENSION 135 0.0006
716 GASTROINTESTINAL DISORDER 57 0.0006
717 MALAISE 279 0.0006
718 DRUG EFFECT INCOMPLETE 23 0.0006
719 DENTAL CARIES 7 0.0006
720 HYPOAESTHESIA 94 0.0006
721 VOMITING 295 0.0006
722 CARDIOGENIC SHOCK 9 0.0006
723 BLOOD CALCIUM DECREASED 7 0.0006
724 PYREXIA 213 0.0006
725 GENERAL PHYSICAL HEALTH DETERIORATION 71 0.0006
726 MICTURITION URGENCY 7 0.0006
727 SHOCK 14 0.0006
728 FATIGUE 473 0.0006
729 PHOTOSENSITIVITY REACTION 10 0.0006
730 RESPIRATORY DISORDER 18 0.0006
731 DRY EYE 30 0.0006
732 ANAPHYLACTIC REACTION 33 0.0006
733 PRODUCT PRESCRIBING ISSUE 13 0.0006
734 ASTHENIA 224 0.0006
735 NASAL CONGESTION 35 0.0006
736 VERTIGO 36 0.0006
737 LIVER DISORDER 26 0.0006
738 ACUTE HEPATIC FAILURE 8 0.0006
739 HEPATOTOXICITY 13 0.0006
740 SWELLING FACE 38 0.0006
741 MUSCULOSKELETAL CHEST PAIN 9 0.0006
742 RESPIRATORY ARREST 16 0.0006
743 HEPATITIS C 7 0.0006
744 PARAESTHESIA 91 0.0006
745 WEIGHT DECREASED 160 0.0006
746 CHOLESTASIS 11 0.0006
747 CARDIAC ARREST 47 0.0006
748 CARDIAC DISORDER 53 0.0006
749 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
750 ISCHAEMIC STROKE 10 0.0006
751 DRUG WITHDRAWAL SYNDROME 49 0.0006
752 GLYCOSYLATED HAEMOGLOBIN INCREASED 14 0.0006
753 PRODUCT DOSE OMISSION ISSUE 163 0.0006
754 BACK DISORDER 9 0.0006
755 CARDIOVASCULAR DISORDER 14 0.0006
756 FALL 183 0.0005
757 ROAD TRAFFIC ACCIDENT 23 0.0005
758 LIMB DISCOMFORT 17 0.0005
759 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
760 INJECTION SITE INDURATION 7 0.0005
761 FEELING HOT 33 0.0005
762 COLON CANCER 8 0.0005
763 WOUND 15 0.0005
764 ABDOMINAL DISTENSION 56 0.0005
765 UNEVALUABLE EVENT 40 0.0005
766 DYSMENORRHOEA 7 0.0005
767 DEHYDRATION 70 0.0005
768 RED BLOOD CELL COUNT DECREASED 15 0.0005
769 EYE HAEMORRHAGE 7 0.0005
770 SWELLING 49 0.0005
771 HYPERSENSITIVITY 97 0.0005
772 HEADACHE 325 0.0005
773 CHRONIC KIDNEY DISEASE 39 0.0005
774 HAEMORRHOIDS 10 0.0005
775 PERIPHERAL COLDNESS 7 0.0005
776 DYSPNOEA 288 0.0005
777 ACCIDENT 6 0.0005
778 PAIN IN JAW 14 0.0005
779 UNDERDOSE 36 0.0005
780 PANCREATITIS 26 0.0005
781 DISCOMFORT 30 0.0005
782 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 9 0.0005
783 HAEMOGLOBIN DECREASED 50 0.0005
784 EYE DISORDER 16 0.0005
785 DRUG DEPENDENCE 78 0.0005
786 GASTROOESOPHAGEAL REFLUX DISEASE 39 0.0005
787 EXPIRED PRODUCT ADMINISTERED 16 0.0005
788 VIRAL INFECTION 16 0.0005
789 OXYGEN SATURATION DECREASED 27 0.0005
790 COAGULOPATHY 8 0.0005
791 DECREASED APPETITE 111 0.0005
792 PALLOR 13 0.0005
793 BLOOD PRESSURE INCREASED 72 0.0005
794 PLATELET COUNT DECREASED 50 0.0005
795 HEPATITIS 12 0.0005
796 SCAR 8 0.0005
797 BLOOD POTASSIUM DECREASED 14 0.0005
798 ACCIDENTAL OVERDOSE 17 0.0005
799 PRODUCT QUALITY ISSUE 63 0.0005
800 EAR PAIN 9 0.0005
801 ATRIAL FIBRILLATION 45 0.0005
802 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
803 INJECTION SITE MASS 17 0.0005
804 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
805 TINNITUS 21 0.0005
806 INTENTIONAL DOSE OMISSION 13 0.0005
807 BLOOD PRESSURE ABNORMAL 9 0.0005
808 NEURALGIA 11 0.0005
809 TENDONITIS 7 0.0005
810 LYMPHADENOPATHY 16 0.0005
811 BLOOD PRESSURE DECREASED 30 0.0005
812 DRUG ERUPTION 8 0.0005
813 TOOTH DISORDER 10 0.0004
814 NERVOUS SYSTEM DISORDER 14 0.0004
815 CARDIAC FAILURE 36 0.0004
816 PNEUMONIA 145 0.0004
817 CYANOSIS 7 0.0004
818 OCULAR HYPERAEMIA 21 0.0004
819 HEAD INJURY 14 0.0004
820 ABDOMINAL PAIN 101 0.0004
821 PULMONARY HYPERTENSION 9 0.0004
822 NECK PAIN 24 0.0004
823 CORONARY ARTERY DISEASE 13 0.0004
824 DYSPHONIA 25 0.0004
825 HEPATIC CIRRHOSIS 8 0.0004
826 RESPIRATORY TRACT INFECTION 11 0.0004
827 FOOT FRACTURE 8 0.0004
828 BLOOD URINE PRESENT 8 0.0004
829 GASTRIC ULCER 8 0.0004
830 ECZEMA 22 0.0004
831 MUSCULOSKELETAL DISORDER 8 0.0004
832 SKIN DISORDER 14 0.0004
833 GLAUCOMA 8 0.0004
834 MENORRHAGIA 8 0.0004
835 RENAL FAILURE 54 0.0004
836 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 82 0.0004
837 SYRINGE ISSUE 7 0.0004
838 PRODUCT PHYSICAL ISSUE 8 0.0004
839 DYSPEPSIA 39 0.0004
840 BLOOD GLUCOSE DECREASED 19 0.0004
841 CEREBROVASCULAR ACCIDENT 67 0.0004
842 BLINDNESS 16 0.0004
843 SURGERY 23 0.0004
844 NAUSEA 305 0.0004
845 ABDOMINAL DISCOMFORT 64 0.0004
846 OROPHARYNGEAL PAIN 35 0.0004
847 CELLULITIS 19 0.0004
848 BLOOD PRESSURE FLUCTUATION 9 0.0004
849 ACUTE MYOCARDIAL INFARCTION 11 0.0004
850 NIGHT SWEATS 12 0.0004
851 EXTRA DOSE ADMINISTERED 15 0.0004
852 SKIN DISCOLOURATION 17 0.0004
853 CEREBRAL INFARCTION 9 0.0004
854 CHILLS 43 0.0004
855 PRODUCT SUBSTITUTION ISSUE 21 0.0004
856 OSTEONECROSIS OF JAW 9 0.0004
857 ANGIOEDEMA 16 0.0004
858 BACK PAIN 84 0.0004
859 PLEURAL EFFUSION 22 0.0004
860 ABDOMINAL PAIN UPPER 74 0.0004
861 EYE PAIN 20 0.0004
862 RENAL FAILURE ACUTE 15 0.0004
863 RASH 154 0.0004
864 PRESCRIBED UNDERDOSE 7 0.0004
865 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
866 EYE SWELLING 13 0.0003
867 ANAPHYLACTIC SHOCK 9 0.0003
868 NEPHROLITHIASIS 16 0.0003
869 FEEDING DISORDER 7 0.0003
870 SEPTIC SHOCK 15 0.0003
871 GASTRITIS 9 0.0003
872 HEART RATE DECREASED 12 0.0003
873 URTICARIA 57 0.0003
874 CHOLELITHIASIS 11 0.0003
875 MIGRAINE 32 0.0003
876 MOUTH ULCERATION 7 0.0003
877 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
878 MYOCARDIAL INFARCTION 57 0.0003
879 LIVER FUNCTION TEST INCREASED 7 0.0003
880 PAIN 199 0.0003
881 ARTHROPATHY 18 0.0003
882 FEMUR FRACTURE 10 0.0003
883 HAEMATURIA 11 0.0003
884 EPISTAXIS 24 0.0003
885 URINARY TRACT INFECTION 54 0.0003
886 ALOPECIA 62 0.0003
887 PULMONARY OEDEMA 14 0.0003
888 HYPOXIA 11 0.0003
889 PAIN IN EXTREMITY 92 0.0003
890 NEEDLE ISSUE 9 0.0003
891 DYSSTASIA 9 0.0003
892 INTENTIONAL PRODUCT USE ISSUE 27 0.0003
893 INFLUENZA LIKE ILLNESS 25 0.0003
894 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
895 ILLNESS 31 0.0003
896 DIARRHOEA 194 0.0003
897 PREMATURE BABY 9 0.0003
898 JAUNDICE 8 0.0003
899 BLOOD BILIRUBIN INCREASED 8 0.0003
900 RHINORRHOEA 19 0.0003
901 MUSCULOSKELETAL PAIN 15 0.0003
902 THROMBOSIS 23 0.0003
903 AGEUSIA 7 0.0003
904 CEREBRAL HAEMORRHAGE 10 0.0003
905 HOT FLUSH 21 0.0003
906 ANAEMIA 53 0.0003
907 HAEMATEMESIS 7 0.0003
908 FLUID RETENTION 14 0.0003
909 ABORTION SPONTANEOUS 11 0.0003
910 PRODUCTIVE COUGH 13 0.0003
911 BURNING SENSATION 19 0.0003
912 LIP SWELLING 9 0.0003
913 HAEMATOMA 7 0.0003
914 FUNGAL INFECTION 9 0.0003
915 SEPSIS 30 0.0003
916 PANCYTOPENIA 15 0.0003
917 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
918 EYE IRRITATION 15 0.0003
919 PERIPHERAL SWELLING 40 0.0003
920 FOETAL EXPOSURE DURING PREGNANCY 21 0.0003
921 JOINT SWELLING 31 0.0003
922 COUGH 72 0.0003
923 HYPOACUSIS 11 0.0003
924 SKIN LESION 7 0.0003
925 HAEMATOCHEZIA 14 0.0003
926 VAGINAL HAEMORRHAGE 11 0.0003
927 INFLAMMATION 13 0.0003
928 SKIN BURNING SENSATION 18 0.0003
929 ACNE 19 0.0003
930 THROMBOCYTOPENIA 28 0.0003
931 MATERNAL EXPOSURE DURING PREGNANCY 22 0.0002
932 STAPHYLOCOCCAL INFECTION 8 0.0002
933 LABORATORY TEST ABNORMAL 7 0.0002
934 MOBILITY DECREASED 17 0.0002
935 RENAL DISORDER 11 0.0002
936 RENAL INJURY 7 0.0002
937 PRURITUS 90 0.0002
938 GASTRIC DISORDER 8 0.0002
939 HEPATIC FAILURE 7 0.0002
940 RASH ERYTHEMATOUS 11 0.0002
941 DYSGEUSIA 17 0.0002
942 RASH MACULAR 8 0.0002
943 COVID-19 40 0.0002
944 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
945 DEPENDENCE 12 0.0002
946 OSTEOPOROSIS 9 0.0002
947 CONTUSION 21 0.0002
948 INJECTION SITE REACTION 15 0.0002
949 BRONCHITIS 16 0.0002
950 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
951 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
952 ASTHMA 23 0.0002
953 CATARACT 12 0.0002
954 ARTHRALGIA 83 0.0002
955 FLATULENCE 11 0.0002
956 INJECTION SITE PAIN 57 0.0002
957 DEATH 160 0.0002
958 RASH PRURITIC 10 0.0002
959 INFLUENZA 20 0.0002
960 ARTHRITIS 14 0.0002
961 ERYTHEMA 36 0.0002
962 NASOPHARYNGITIS 32 0.0002
963 INJECTION SITE SWELLING 13 0.0002
964 INFECTION 24 0.0002
965 CARDIAC FAILURE CONGESTIVE 13 0.0002
966 BLISTER 9 0.0002
967 COLITIS ULCERATIVE 7 0.0002
968 THROAT IRRITATION 7 0.0002
969 THERAPY INTERRUPTED 11 0.0002
970 PSORIASIS 20 0.0002
971 BREAST CANCER 14 0.0002
972 ILL-DEFINED DISORDER 9 0.0001
973 NEUROPATHY PERIPHERAL 14 0.0001
974 MULTIPLE SCLEROSIS 7 0.0001
975 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
976 NO ADVERSE EVENT 25 0.0001
977 FLUSHING 14 0.0001
978 BONE PAIN 8 0.0001
979 WHEEZING 8 0.0001
980 DRY SKIN 17 0.0001
981 DISEASE PROGRESSION 15 0.0001
982 INJECTION SITE HAEMORRHAGE 10 0.0001
983 FEBRILE NEUTROPENIA 8 0.0001
984 NEOPLASM MALIGNANT 8 0.0001
985 SKIN EXFOLIATION 10 0.0001
986 SINUSITIS 12 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
988 INJECTION SITE ERYTHEMA 13 0.0001
989 HAEMORRHAGE 8 0.0001